Advertisement
News
Advertisement

Report: Emerging therapies to boost PAH market

Mon, 10/08/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Sales of therapies to treat pulmonary arterial hypertention, a rare and lifte-threatening disorder caused by a narrowing of the small arteries of the lung, will reach $3.5 billion, thanks to the launch of new novel agents over the next 10 years.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading